LATEST
Janel agreed to acquire EnCor BiotechnologynewNightfood Holdings acquired Jun Long Machine IndustrialnewClimb Global Solutions acquired NeoVADnewValor Energy agreed to acquire Glorious StarOakley Capital / Global Loan Agency ServicesTA Associates / MedEnvision: majority stakeLSEG agreed to acquire OctusStord / AMS Fulfillment: investmentCencora agreed to acquire American Oncology NetworkAPEX / KoraiSmith & Wesson Brands agreed to acquire Long Range IntermediateBose acquired Skullcandy
Open App
ClosedPublished 2 Jun 2022

Qualigen Therapeutics, Inc. /
NanoSynex Ltd.

Qualigen Therapeutics secures majority stake in NanoSynex Ltd.

Terms
Not stated
Stage
Closed
Target: NanoSynex Ltd.
TargetNanoSynex Ltd.
Source · 2 Jun 2022
See the source
Target: NanoSynex Ltd.
TargetNanoSynex Ltd.
01 / BuyerQualigen Therapeutics, Inc.
02 / TargetNanoSynex Ltd.
01

What happened

Qualigen Therapeutics, Inc. closed its acquisition of newly authorized preferred shares in NanoSynex Ltd. for a total purchase price of $600,000.

Qualigen also acquired additional NanoSynex shares from Alpha Capital Anstalt in exchange for company shares and a pre-funded warrant. The filing states that Qualigen acquired a majority stake in NanoSynex.

02

The source

Everything on this page comes from the source below.

01
Source · Source

Qualigen Therapeutics secures majority stake in NanoSynex Ltd.

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.